Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vincera Pharma Inc (VINC)

Vincera Pharma Inc (VINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vincera Pharma Inc 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 USA

www.vincerx.com P: 650-800-6676

Description:

Vincerx Pharma Inc. is a biopharmaceutical company. It focuses on unmet medical needs of patients with cancer through paradigm-shifting therapeutics. Vincerx Pharma Inc. is based in PALO ALTO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 19,914
Enterprise Value, $K 7,064
Shares Outstanding, K 21,413
Annual Sales, $ 0 K
Annual Net Income, $ -40,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,950 K
EBIT, $ -42,610 K
EBITDA, $ -42,320 K
60-Month Beta 1.53
% of Insider Shareholders 22.90%
% of Institutional Shareholders 44.02%
Float, K 16,509
% Float 77.10%
Short Volume Ratio 0.74

Growth:

1-Year Return -41.14%
3-Year Return -94.10%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 03/29/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -1.89
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 64.62%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VINC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -187.73%
Return-on-Assets % -126.26%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.58
Book Value/Share 0.52
Interest Coverage -1.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar